
USE OF AMINOPHYLLINE AND ENALAPRIL IN POSTTRANSPLANT POLYCYTHEMIA
Author(s) -
Marilda Mazzali,
Gentil Alves Filho
Publication year - 1998
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199806150-00009
Subject(s) - enalapril , medicine , aminophylline , hematocrit , phlebotomy , angiotensin converting enzyme , endocrinology , pharmacology , gastroenterology , anesthesia , blood pressure
Posttransplant polycythemia (PTP) affects 6-30% of renal transplant recipients and can result in thromboembolic disease. The pathogenesis of PTP remains unknown and may be multifactorial. Although phlebotomy has previously been the treatment for PTP, drugs such as adenosine receptor antagonists or angiotensin-converting enzyme inhibitors can be used to control PTP.